source
- CMS recalculates 2026 Medicare Advantage star ratings, increasing program volatility and affecting $16 billion in bonusesFederal officials have issued a new memo that recalculates the quality ratings for 2026 Medicare Advantage plans. The change follows another lawsuit from insurers that contest lower star ratings,…
- FDA advisory panel backs Moderna seasonal mRNA flu vaccine after earlier controversyA Food and Drug Administration advisory committee unanimously endorsed Moderna’s seasonal mRNA flu vaccine on Thursday, after the product became the focus of controversy earlier this year when a se…